Controlled Study of Pre‐ and Postoperative Headache in Patients with Sellar Masses ( HEADs ‐ uP Study)
Endocrinology, Diabetes & Metabolism · 2024
DOI: 10.1002/edm2.496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2024. Verfasst von Tessa N A Slagboom und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology & Metabolism, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Headache, Pituitary Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Sellar masses are common intracranial neoplasms. Their clinical manifestations vary widely and include headache. We aimed to determine whether the prevalence and characteristics of headache in patients with sellar tumours differ from the general population and to investigate the effect of tumour resection on this complaint.
Methods
We performed a prospective, controlled study in a single tertiary centre and included 57 patients that underwent transsphenoidal resection for a sellar mass (53% females, mean age 53.5 ± 16.4) and 29 of their partners (controls; 45% females, mean age 54.8 ± 14.9). Outcome measures were prevalence, characteristics and impact of headache 1 month preoperatively and at neurosurgical follow‐up 3 months postoperatively.
Results
Preoperatively, the prevalence of regular headache (≥1 time per month) was higher in patients than in controls (54% vs. 17%, p < 0.001), and patients scored higher on headache impact questionnaires (all p ≤ 0.01). At postoperative follow‐up, headache prevalence decreased in both groups, but the decrease in regular headache frequency and impact was larger in patients than in controls, and no between‐group differences remained.
Conclusions
More than half of patients with sellar tumours suffer from at least once‐monthly headaches, and both regular headache occurrence and impact are higher compared with controls. The more pronounced decrease in headache complaints in patients versus controls at postoperative follow‐up suggests an additional effect of tumour resection next to the factor time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology & Metabolism, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Pituitary Centre Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands.
- Department of Endocrinology & Metabolism, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
- Department of Neurosurgery, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Neuroscience, Amsterdam, The Netherlands.
ORCID-Profile: Tessa N A Slagboom
Zitieren
APA
Slagboom, T. N. A., Boertien, T. M., Bisschop, P. H., Fliers, E., Baaijen, J. C., Hoogmoed, J., & Drent, M. L. (2024). Controlled Study of Pre‐ and Postoperative Headache in Patients with Sellar Masses ( HEADs ‐ uP Study). Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.496
Vancouver
Slagboom TNA, Boertien TM, Bisschop PH, Fliers E, Baaijen JC, Hoogmoed J, et al. Controlled Study of Pre‐ and Postoperative Headache in Patients with Sellar Masses ( HEADs ‐ uP Study). Endocrinology, Diabetes & Metabolism. 2024. doi:10.1002/edm2.496
BibTeX
@article{Slagboom2024,
author = {Slagboom, Tessa N A and Boertien, Tessel M and Bisschop, Peter H and Fliers, Eric and Baaijen, Johannes C and Hoogmoed, Jantien and Drent, Madeleine L},
title = {Controlled Study of Pre‐ and Postoperative Headache in Patients with Sellar Masses ( HEADs ‐ uP Study)},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2024},
doi = {10.1002/edm2.496}
}
EUVIMED